Atera delivers whole-transcriptome spatial analysis with single-cell sensitivity at scale across fresh-frozen and FFPE tissues, removing trade-offs between scale, sensitivity and gene selection through integrated hardware, chemistry and software.

Research teams from the University of Pennsylvania’s June Lab applied Atera to rare glioblastoma samples treated with bivalent CAR T cells, resolving post-treatment immune cells at high spatial resolution, while German Cancer Research Institute uncovered diverse immune landscapes in colorectal tumors previously deemed immune cold.

Leading institutions including the Human Cell Atlas consortium, Macrogen/Psomagen and Bioptimus have committed to deploying Atera, reflecting strong demand for high-throughput spatial biology in discovery, translational research and AI-driven target discovery.

10x Genomics plans to launch a new cloud-based analysis platform optimized for Atera data, aiming to streamline large-scale whole-transcriptome studies and accelerate biological insight generation.